Otezla

DRUG3 trials

Sponsors

L.H. Kircik, M.D., Psoriasis Treatment Center of Central New Jersey, SFA Therapeutics

Conditions

Plaque PsoriasisPsoriasisPsoriasis (PsO)

Phase 2

Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients

Not yet recruitingNCT06863493

SFA TherapeuticsPsoriasis (PsO)

Start: 2025-06-01End: 2026-09-01Target: 125Updated: 2025-03-11

Phase 4

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

CompletedNCT03441789

L.H. Kircik, M.D.Plaque Psoriasis

Start: 2017-09-18End: 2018-10-22Updated: 2019-03-14

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

CompletedNCT03587194

Psoriasis Treatment Center of Central New JerseyPsoriasis

Start: 2018-07-23End: 2019-07-01Updated: 2024-04-16